BrainKey
BrainKey is a San Francisco-based AI platform that analyzes brain MRI scans to identify biomarkers and render interactive 3D visualizations. It serves consumers, physicians, and research institutions through annual subscriptions, 3D-printed brain replicas, and MRI facility partnerships.
- Company typePrivate
- Founded2019
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2C
- OfferingSoftware
What BrainKey does
BrainKey (Brain Key, Inc.) is a San Francisco-based AI healthcare-technology company that operates a cloud platform for analyzing consumer-uploaded brain MRI scans. Its proprietary computer-vision and machine-learning models segment scans into labeled anatomical structures and biomarkers — including the caudate nucleus, hippocampus, amygdala, and frontal lobe — and present findings through interactive 3D visualizations and a dashboard. The platform explicitly disclaims diagnostic intent, positioning itself as an educational and informational tool for users seeking to understand their existing brain imaging, and maintains HIPAA-aligned privacy and data-handling practices without holding FDA clearance for its outputs.
The company monetizes through a non-refundable, auto-renewing annual subscription membership. Supplemental revenue lines include a 3D-printed physical brain replica service (gold-colored and personalized with the customer's name) and the BrainKey Research program, which enrolls consenting users to incorporate de-identified scans into partnered scientific studies. Distribution is product-led and self-serve on brainkey.ai (customers upload existing MRI scans and receive processed results within 1–72 hours), with adjacent partnerships to third-party MRI facilities (e.g., Cottage Health) that channel users into the platform. The customer base spans individual consumers and patients, physicians and clinicians reviewing patient scans, and research institutions.
BrainKey pursues a two-tier go-to-market: a direct-to-consumer PLG motion for paid memberships and physical replicas, and a research-and-institutional tier built through collaborations with Stanford Medicine, UCLA, Penn State College of Medicine, CHU Toulouse, the University of Toulouse, the Alzheimer's Association, and Cyber Valley. Scientific positioning is reinforced by an advisory team with 50+ peer-reviewed publications in journals such as Nature Neuroscience, Biological Psychiatry, and JAMA Psychiatry. The company was founded in 2018 by neuroscientist Dr. Owen Philips following Y Combinator's 2019 cohort, is backed by Y Combinator, Longevity Tech Fund, Joyance Partners, Soma Capital, Divergent Investments, Human Longevity, StartX, and Amino Capital, and operates with a team in the 1–10 employee range per third-party firmographics.
BrainKey firmographics
Firmographics- Name
- BrainKey
- Legal name
- Brain Key, Inc.
- Website
- https://brainkey.ai
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BrainKey is a San Francisco-based AI platform that analyzes brain MRI scans to identify biomarkers and render interactive 3D visualizations. It serves consumers, physicians, and research institutions through annual subscriptions, 3D-printed brain replicas, and MRI facility partnerships.
- Ownership category
- akta.pro rank
BrainKey industry classification
Industry- Product category
- AI Neuroimaging Software
- NAICS
- Computer Systems Design and Related Services (54151), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (51821)
- SIC
- Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
- akta.pro primary industry
- Medical Imaging AI (HDAAAEAH)
- akta.pro secondary industry
- Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables) (HLAHACAE)
Keywords
Where BrainKey is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
BrainKey business model
Business model- GTM type
- B2C
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain
Revenue model
- Subscription/Membership Service: BrainKey operates on a subscription membership model where customers pay to become fully subscribing members. Once a customer makes a payment to become a fully subscribing member, the completed transaction is non-refundable. Subscriptions auto-renew annually if not cancelled.
- 3D Brain Printing: Customers can order physical 3D printed replicas of their brain. The printed brains feature gold coloring on a white base with the customer's name on the front and BrainKey logo on the side.
- MRI Scan Processing: BrainKey processes and analyzes brain scans uploaded by customers. The company has partnerships with third-party MRI facilities where BrainKey Scans (3D brain MRI scans) are performed. Processing turnaround from upload takes 1-72 hours.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Subscription membership (specific tiers not disclosed) |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels5 records
BrainKey product offering
Product offeringCore offering
BrainKey operates an AI-powered platform that analyzes MRI brain scans to uncover key biomarkers and assess brain health at a biological level, transforming complex anatomical imaging data into interactive 3D visualizations. Customers upload brain MRI scans through a self-service web app and receive processed analysis results within 1-72 hours. The company also offers a physical 3D brain printing add-on service and a BrainKey Research program for de-identified scientific data contribution.
Product overview
BrainKey is a unified AI-powered health platform centered on brain MRI analysis. The core BrainKey MRI Analysis Platform processes brain scans to generate 3D visualizations and biomarker assessments, accessible through the BrainKey Dashboard. Additional offerings include a 3D Brain Printing service for physical replicas and the BrainKey Research program for scientific contribution. The platform is designed to make brain anatomy measurable, visible, and easier to interpret, empowering physicians with advanced analytical tools.
Differentiator
Problem solved
Functional benefit
Products and services
- BrainKey MRI Analysis Platform AI-powered cloud platform that processes uploaded MRI brain scans to identify key biomarkers and assess brain health at a biological level, providing quantitative 3D visualizations of brain anatomy (caudate nucleus, frontal lobe, brainstem, hippocampus, cerebellum, amygdala) for individual consumers seeking proactive brain health insights.
- 3D Brain Printing Service that produces a custom physical 3D-printed replica of a customer's brain based on their MRI scan, finished in gold color on a white base with the customer's name on the front and the BrainKey logo on the side, intended for personal, educational, or display purposes.
Quantifiable outcome
- Brain scan processing turnaround of 1-72 hours from upload to completion
Companies that use BrainKey
Customer profileSegments3 records
Ideal customer profiles3 records
BrainKey technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature4 records
BrainKey partnerships and signals
Strategic signalPartnerships
Nine partnerships are on record, tiered core and minor.
- Stanford MedicinecoreResearch partner helping to drive BrainKey forward. The Stanford AI Club was founded by Owen Philips while at Stanford, where he began applying AI to neuroimaging. Stanford is a key research collaboration partner.
- Penn State College of MedicinecoreResearch partner helping to drive BrainKey forward. Listed among collaborators and research partners.
- Cyber ValleycoreResearch partner helping to drive BrainKey forward. Cyber Valley is a European research consortium in machine learning and robotics.
- Alzheimer's AssociationcoreResearch partner helping to drive BrainKey forward. Alzheimer's Association partnership aligns with BrainKey's mission to prevent cognitive decline and dementia.
- Berlin School of Brain and BrainminorResearch partner helping to drive BrainKey forward.
- UCLA Geffen School of MedicinecoreResearch partner helping to drive BrainKey forward. UCLA is where founder Owen Philips conducted neuroscience research.
- CHU ToulousecoreResearch partner helping to drive BrainKey forward. University of Toulouse is where founder Owen Philips and Prof. Olivier Rascol conducted research.
- Cottage HealthminorResearch partner helping to drive BrainKey forward. Cottage Health is a healthcare system in Santa Barbara, California.
- Stanford AI ClubminorAI interest group launched by Owen Philips while at Stanford in 2017, where he began applying AI to neuroimaging. This was the seed for BrainKey.
Scale indicators2 records
Recent moves6 records
Expansion highlights6 records
BrainKey competitors and assessment
Company assessmentDirect peers
- icometrix: icometrix provides AI-based brain MRI analysis software (icobrain) for quantification of MRI biomarkers in neurology, including multiple sclerosis and dementia — the closest direct competitor to BrainKey's structural MRI biomarker focus, with deeper clinical traction and FDA clearances.
- QMENTA: QMENTA operates an AI-powered neuroimaging platform that processes brain MRI scans and offers cloud-based analysis and biomarker extraction, directly overlapping BrainKey's core workflow of uploading MRI data and receiving quantitative brain assessments.
- ADM Diagnostics: ADM Diagnostics delivers quantitative MRI post-processing services for neurological and psychiatric conditions, including brain volumetry, very similar to BrainKey's biomarker-driven structural brain analysis approach.
- BrainSpec: BrainSpec is a software platform for brain MR spectroscopy analysis, a specialty neuroimaging tool for biomarker quantification — comparable to BrainKey as a focused brain-imaging biomarker analytics company serving both clinical researchers and consumers.
- SyntheticMR: SyntheticMR offers quantitative MRI software (SyMRI) that delivers automated, objective measurements of brain tissue, comparable to BrainKey's automated biomarker extraction from structural MRI scans.
- Cortechs.ai: Cortechs.ai develops AI-driven quantitative MRI analysis tools (e.g., NeuroQuant) for brain volumetrics used in clinical practice — a direct competitor to BrainKey's structural MRI biomarker quantification use case with established clinical deployments.
Broad incumbents
- Arterys (Tempus): Arterys (now part of Tempus) provides cloud-native AI medical imaging analytics across multiple modalities including neuro MRI — a broader incumbent that competes for the same AI imaging budgets but spans cardiology, oncology, and neurology.
- RapidAI: RapidAI offers AI-powered imaging analysis primarily for stroke and neurology workflows, overlapping with BrainKey's brain MRI domain but operating at much larger scale with hospital and reimbursement-grade integrations.
- Human Longevity Inc. Human Longevity provides premium whole-body and brain imaging paired with genomic and AI-driven health insights for longevity-focused consumers — a broader incumbent in the consumer brain-health/longevity space and also a listed BrainKey investor.
Emerging players
- Darmiyan: Darmiyan offers AI-powered brain MRI analysis for early detection of Alzheimer's disease, an emerging player with similar brain-health biomarker positioning to BrainKey but focused on a single high-value neurodegenerative indication.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BrainKey social profiles
Digital presenceBrainKey compliance and trust
Trust signalCompliance1 record
BrainKey financial estimates
Financial estimateRevenue estimate
Valuation estimate
BrainKey leadership team
Management profileNumber of profiles
Profiles8 records
BrainKey funding detail
Funding detailFunding overview
Funding rounds3 records
Investors6 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BrainKey M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BrainKey
What does BrainKey do?
BrainKey operates an AI-powered platform that analyzes MRI brain scans to uncover key biomarkers and assess brain health at a biological level, transforming complex anatomical imaging data into interactive 3D visualizations. Customers upload brain MRI scans through a self-service web app and receive processed analysis results within 1-72 hours. The company also offers a physical 3D brain printing add-on service and a BrainKey Research program for de-identified scientific data contribution.
Is BrainKey a public or private company?
BrainKey is a private company. It is classified as venture growth investor backed and is currently operating.
When was BrainKey founded?
BrainKey was founded in 2019. It employs 1 to 10 people.
Where is BrainKey based?
BrainKey is headquartered in San Francisco, United States, in the North America region.
How does BrainKey make money?
Three revenue lines are on record. Subscription/Membership Service is the primary driver. The others are 3D Brain Printing and MRI Scan Processing.
Who are BrainKey's main competitors?
Direct peers on record are icometrix, QMENTA, ADM Diagnostics, BrainSpec, SyntheticMR and Cortechs.ai. Broad incumbents are Arterys (Tempus), RapidAI and Human Longevity Inc.. Darmiyan is listed as an emerging player.
Does BrainKey have an API?
No public API is recorded for BrainKey.
What industry is BrainKey in?
BrainKey's product category is AI Neuroimaging Software. Its primary akta.pro industry code is HDAAAEAH, Medical Imaging AI, with a secondary code of HLAHACAE, Neurological Monitoring (EEG, Seizure/Sleep/Neuro Wearables). Its NAICS code is 54151 and its SIC code is 7372.